InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,174.00
(
1.14%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.08
(
-0.13%
)
Bitcoin
61,805.44
(
0.00%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 421

Tuesday, 10/20/2020 4:10:07 PM

Tuesday, October 20, 2020 4:10:07 PM

Post# of 438
VYNE is the name of the Dermatology therapeutics concern that formed when MNLO & FOMX combined.

It markets 2 products:

1) Amzeeq has grown scips 20% since the beginning of the April shutdown. It is a treatment for cystic acne.

2) Zilxi, the rosacea treatment has improving health plan coverage.

Potential future catalysts include potential ex-US partnerships and milestones for pipeline asset FCD105 ( a treatment for Acne Vulgaris).

Earnings are 2/5/8/11. I'd be curious to hear the next earnings scheduled 11/4/20.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up